Status:
RECRUITING
Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal Morbidity
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Genital Herpes Simplex
Maternal Morbidity
Eligibility:
FEMALE
18-55 years
Brief Summary
Severe Maternal Morbidity (SMM) has been associated with maternal mortality, fetal risk, and long-term maternal risk. African American (AA) women are at consistently higher risk than White women. Howe...
Detailed Description
Severe Maternal Morbidity (SMM), as defined by the CDC, has been repeatedly associated with maternal mortality, fetal risk, and long-term maternal risk. SMM is one of PCORI's research priorities (Spec...
Eligibility Criteria
Inclusion
- Kaiser Permanente Northern California Members
- Pregnant women
Exclusion
- Non Kaiser Permanente Northern California Members
- Non-pregnant women
Key Trial Info
Start Date :
January 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
339000 Patients enrolled
Trial Details
Trial ID
NCT05429346
Start Date
January 8 2023
End Date
April 30 2026
Last Update
April 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Research, Kaiser Permanente Northern California
Oakland, California, United States, 94312